摘要
背景:细胞因子(如TNF-α和IL-6)水平的升高导致急性缺血性心脏病(AIHD)的炎症性激增。 目的:研究AIHD患者血清中高水平的肌酸激酶亚型2(DCN-2)对细胞因子表达的调节作用。确定雌激素对炎症反应的抑制作用。 方法:对经同意的AIHD患者和正常志愿者进行血液采集。用高铁血红蛋白法合成一氧化氮(NO),用酶联免疫吸附试验(ELISA)和蛋白质印迹法测定TNF-α和IL-6的表达。 结果:(DCN-2)在正常中性粒细胞溶液中120nm孵育2h,TNF-α从3.82±1.53pg/ml增加到20.7±6.9pg/ml,IL-6从3.27±1.52pg/ml增加到47.07±3.4pg/ml,AIHD患者细胞因子水平为18.3-27.3pg/ml,中位值为21.86pg/ml(TNF-α),IL-6水平为23.54-52.73pg/ml。伊恩值42.16pg/ml,雌性激素雌激素0.6nM雌三醇治疗45min后,120nM DCN-2治疗正常中性粒细胞的细胞因子水平升高。用Western blot技术进一步测定了DCN-2在中性粒细胞中诱导的TNF-α的合成,其增稠带强度为TNF-α。雌三醇(0.6nM)对DCN-2诱导的一氧化氮(NO)合成的抑制也有影响,从0nmol-no/ml到0.56nmol/ml,随后TNF-α水平的降低与NO水平的升高有关。 结论:应激诱导AIHD组织DCN-2生成可促进炎症反应。类固醇分子如雌三醇在一氧化氮合成中通过降低DCN-2反应起到保护作用。
关键词: 急性缺血性心脏病,炎症,肿瘤坏死因子-α,白细胞介素-6,去皮质素亚型-2。
Current Molecular Medicine
Title:Estriol Inhibits Dermcidin Isoform-2 Induced Inflammatory Cytokine Expression Via Nitric Oxide Synthesis in Human Neutrophil
Volume: 18 Issue: 10
关键词: 急性缺血性心脏病,炎症,肿瘤坏死因子-α,白细胞介素-6,去皮质素亚型-2。
摘要: Background: An increase in the level of cytokines like TNF-α and IL-6 causes the inflammatory surge in acute ischemic heart disease (AIHD).
Objective: A high-level dermcidin isoform-2 (DCN-2) occurrence in AIHD was subjected to determine a possible regulation of cytokines expression. The effect of estrogen to counteract the inflammatory response was determined.
Methods: Blood was collected from AIHD patients and normal volunteers with consent. Nitric oxide (NO) synthesis was done with methemoglobin method.TNF-α and IL-6 expression were determined by ELISA and Western blot.
Results: (DCN-2) incubation with 120nM to the normal neutrophil solution for 2h resulted in the increase of TNF-α from 3.82±1.53pg/ml to 20.7±6.9pg/ml and IL-6 from 3.27±1.52pg/ml to 47.07±3.4pg/ml. In AIHD patients, the cytokine level was18.3- 27.3pg/ml, with a median value 21.86pg/ml (TNF-α) and IL-6 level was 23.54- 52.73pg/ml, with a median value 42.16pg/ml. Treatment with 0.6nM estriol, a kind of female steroid hormone estrogen for 45min decreased the elevated cytokine level in 120nM DCN-2 treated normal neutrophils. DCN-2 induced TNF-α synthesis in neutrophils was further determined by Western blot technique with a thickened band intensity of TNF-α. Estriol (0.6nM) treatment also influenced the DCN-2 induced inhibition of nitric oxide (NO) synthesis from 0nmol NO/ml to 0.56nmol/ml. The subsequent reduction of TNF-α level correlates the increase of NO level.
Conclusion: In conclusion, the stress-induced DCN-2 production in AIHD propagates the inflammatory response. Steroid molecule like estriol plays a protective role by reducing DCN-2 responses in the NO synthesis.
Export Options
About this article
Cite this article as:
Estriol Inhibits Dermcidin Isoform-2 Induced Inflammatory Cytokine Expression Via Nitric Oxide Synthesis in Human Neutrophil, Current Molecular Medicine 2018; 18 (10) . https://dx.doi.org/10.2174/1566524019666190208095754
DOI https://dx.doi.org/10.2174/1566524019666190208095754 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation
Recent Patents on Cardiovascular Drug Discovery Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Editorial [Bioengineering and Clinical Perspectives in Diagnostic and Therapeutic Applications of Microbubbles (Executive Guest Editor: Theodore G. Papaioannou)]
Current Pharmaceutical Design Fluoride Effects: The Two Faces of Janus
Current Medicinal Chemistry Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
Current Vascular Pharmacology Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research Cell Adhesion Molecules and Cadmium
Current Chemical Biology Identification and Characterization of a Novel Oligomeric Decaprenyl Diphosphate Synthase
Protein & Peptide Letters Editorial [Hot Topic: New Medicinal Chemistry Approaches for the Treatment of Cardiovascular Disease (Guest Editor: Dennis Lee)]
Current Topics in Medicinal Chemistry Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti- Rheumatic Drugs (DMARDs)
Current Vascular Pharmacology Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series
Current Alzheimer Research Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Current Topics in Medicinal Chemistry Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Molecular Imaging of Vascular Inflammation
Current Pharmaceutical Design Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Current Diabetes Reviews Forkhead Genes: Their Role and Impact on Ocular Developmental Diseases
Current Genomics Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Three Dimensional Echocardiography: Recent Trends in Segmen tation Methods
Current Medical Imaging